Lingbo Li is a Principal Medical Writer with expertise in complex clinical documents across various therapeutic areas, including oncology, immunology, and neuroscience. Currently serving as a Senior Medical Writer at Merck since 2017, Lingbo focuses on authoring submissions for global regulatory agencies and developing strategies for high-quality documentation. Previously, Lingbo worked at Stanford University as a Bioresearch Strategist and Researcher, where they organized workshops and supervised interdisciplinary projects. Lingbo holds a Ph.D. in Neuroscience and Genetics from the University of Pennsylvania, attained in 2019.
This person is not in the org chart
This person is not in any teams
This person is not in any offices